The FDA will approve a drug for the treatment of senescence (aging) before the end of the decade (before 2030)
Gesundheit & MedizinOne-Off3J
Manifold MarketsKein KYCVerifizierte AuflösungsdatenOrdentlich kalibriertAktuelle Community-PrognoseNein 85.8%
Prognostiker
36
Fragetyp
binary
Methodik
Play-money forecasting platform
Quellentyp
Prognose
Marktdaten
Aktualisiert vor 23 Minuten
3. Jan. 23, 02:39 UTC31. Dez. 29, 23:59 UTC
Trends
Verwandte Märkte
Verwandte Fragen als Kontext, kein Vergleich gleichwertiger Kontrakte.
By 2030, will the FDA approve any drug in combination with a checkpoint blockade therapy that substantially reduces immune escape?
Manifold MarketsWill the FDA approve Viagra as a treatment for Alzheimer's before 2030?
Manifold MarketsWill the FDA approve MAIA Biotechnology's THIO-101 for the treatment of advanced Non-Small Cell Lung Cancer by Jan 2030?
Manifold MarketsWill the FDA approve any drug for an aging indication in humans before January 1, 2035?
Manifold MarketsWill the FDA approve a psilocybin treatment during 2026?
FutuurWill the FDA approve VERVE-102?
KalshiRegeln
https://www.wired.com/story/drugs-aging-medicine-biotech/
- Jan 4, 1:44pm: The FDA will approve a drug for the treatment of senesense (aging) before the end of the decade (before 2030) → The FDA will approve a drug for the treatment of senescence (aging) before the end of the decade (before 2030)
